Legal & General Group’s Amgen AMGN Stock Holding History

Legal & General Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.36B	Buy	3,870,863 +59,412	+2%	+$21.2M	0.32%	56
2025 Q4	$1.25B	Buy	3,811,451 +94,494	+3%	+$30M	0.28%	63
2025 Q3	$1.05B	Buy	3,716,957 +177,325	+5%	+$51.4M	0.24%	77
2025 Q2	$988M	Sell	3,539,632 -121,632	-3%	-$34.5M	0.25%	71
2025 Q1	$1.14B	Buy	3,661,264 +78,019	+2%	+$23M	0.31%	49
2024 Q4	$934M	Sell	3,583,245 -224,061	-6%	-$66.5M	0.25%	67
2024 Q3	$1.23B	Buy	3,807,306 +27,998	+0.7%	+$9.16M	0.32%	48
2024 Q2	$1.18B	Sell	3,779,308 -281,384	-7%	-$82.7M	0.33%	43
2024 Q1	$1.15B	Sell	4,060,692 -52,592	-1%	-$15.4M	0.33%	49
2023 Q4	$1.18B	Buy	4,113,284 +52,666	+1%	+$14.3M	0.37%	42
2023 Q3	$1.09B	Sell	4,060,618 -152,947	-4%	-$38.2M	0.38%	40
2023 Q2	$935M	Buy	4,213,565 +129,681	+3%	+$30.1M	0.3%	54
2023 Q1	$987M	Buy	4,083,884 +17,109	+0.4%	+$4.2M	0.35%	48
2022 Q4	$1.07B	Sell	4,066,775 -188,750	-4%	-$50.6M	0.41%	41
2022 Q3	$959M	Sell	4,255,525 -170,586	-4%	-$41.3M	0.37%	42
2022 Q2	$1.08B	Sell	4,426,111 -102,706	-2%	-$25.2M	0.38%	48
2022 Q1	$1.1B	Buy	4,528,817 +247,748	+6%	+$56.9M	0.33%	54
2021 Q4	$963M	Sell	4,281,069 -83,395	-2%	-$17.6M	0.29%	60
2021 Q3	$928M	Buy	4,364,464 +146,679	+3%	+$33.8M	0.3%	60
2021 Q2	$1.03B	Buy	4,217,785 +244,578	+6%	+$60.2M	0.34%	53
2021 Q1	$989M	Sell	3,973,207 -75,289	-2%	-$18M	0.37%	50
2020 Q4	$931M	Buy	4,048,496 +49,631	+1%	+$11.4M	0.36%	50
2020 Q3	$1.02B	Sell	3,998,865 -24,154	-0.6%	-$5.98M	0.45%	39
2020 Q2	$949M	Buy	4,023,019 +154,051	+4%	+$35.1M	0.46%	40
2020 Q1	$785M	Buy	3,868,968 +41,227	+1%	+$9.01M	0.46%	41
2019 Q4	$923M	Sell	3,827,741 -2,646	-0.1%	-$583K	0.44%	40
2019 Q3	$741M	Sell	3,830,387 -8,723	-0.2%	-$1.67M	0.39%	47
2019 Q2	$707M	Sell	3,839,110 -123,279	-3%	-$22.1M	0.38%	48
2019 Q1	$753M	Buy	3,962,389 +720,809	+22%	+$138M	0.43%	41
2018 Q4	$631M	Buy	3,241,580 +174,360	+6%	+$34M	0.49%	35
2018 Q3	$636M	Sell	3,067,220 -12,434	-0.4%	-$2.45M	0.46%	40
2018 Q2	$568M	Sell	3,079,654 -352,230	-10%	-$62.3M	0.44%	41
2018 Q1	$585M	Sell	3,431,884 -271,116	-7%	-$49.8M	0.45%	42
2017 Q4	$644M	Sell	3,703,000 -78,891	-2%	-$14M	0.47%	42
2017 Q3	$705M	Buy	3,781,891 +60,532	+2%	+$10.7M	0.53%	36
2017 Q2	$641M	Buy	3,721,359 +90,615	+2%	+$14.7M	0.52%	36
2017 Q1	$596M	Buy	3,630,744 +161,934	+5%	+$26.9M	0.51%	35
2016 Q4	$507M	Buy	3,468,810 +19,052	+0.6%	+$2.87M	0.47%	36
2016 Q3	$575M	Buy	3,449,758 +26,550	+0.8%	+$4.49M	0.58%	34
2016 Q2	$521M	Buy	3,423,208 +160,122	+5%	+$24.9M	0.55%	37
2016 Q1	$489M	Buy	3,263,086 +32,086	+1%	+$4.77M	0.54%	38
2015 Q4	$524M	Buy	3,231,000 +94,032	+3%	+$14.8M	0.59%	35
2015 Q3	$434M	Buy	3,136,968 +98,301	+3%	+$15.5M	0.53%	38
2015 Q2	$466M	Buy	3,038,667 +30,735	+1%	+$4.92M	0.55%	37
2015 Q1	$481M	Sell	3,007,932 -52,857	-2%	-$8.32M	0.57%	34
2014 Q4	$488M	Sell	3,060,789 -90,866	-3%	-$14.2M	0.57%	33
2014 Q3	$443M	Sell	3,151,655 -214,699	-6%	-$28M	0.53%	35
2014 Q2	$399M	Buy	3,366,354 +59,690	+2%	+$6.91M	0.46%	41
2014 Q1	$408M	Sell	3,306,664 -58,790	-2%	-$7.13M	0.5%	39
2013 Q4	$384M	Sell	3,365,454 -34,124	-1%	-$3.88M	0.47%	44
2013 Q3	$381M	Sell	3,399,578 -80,689	-2%	-$8.75M	0.5%	38
2013 Q2	$343M	Buy	+3,480,267	New	+$361M	0.47%	38

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Legal & General Group's AMGN Position: Q1 2026 in Review

Legal & General Group increased its Amgen (AMGN) stake by 1.6% in Q1 2026, buying an estimated $21.2M and bringing the position to 3,870,863 shares worth $1.36B. The position accounts for 0.32% of the portfolio, ranked #56.

Legal & General Group first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Legal & General Group held 3,870,863 shares of Amgen worth $1.36B as of Q1 2026.
Legal & General Group bought 59,412 Amgen shares in Q1 2026, an estimated $21.2M.
Amgen made up 0.32% of Legal & General Group's portfolio in Q1 2026, its #56 holding.
Legal & General Group first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.